Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.
about
The role of renin-angiotensin aldosterone system related micro-ribonucleic acids in hypertensionAll's well that transcribes well: non-coding RNAs and post-stroke brain damageExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.microRNAs in Essential Hypertension and Blood Pressure Regulation.Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study.Impact of the AGTR1 A1166C polymorphism on subcortical hyperintensities and cognition in healthy older adults.Exercise training in hypertension: Role of microRNAs.The ACE2/Apelin Signaling, MicroRNAs, and Hypertension.Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels.miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.Mechanisms and therapeutic potential of microRNAs in hypertension.Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesVariations of the angiotensin II type 1 receptor gene are associated with extreme human longevityAngiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure.Renin-angiotensin system gene polymorphisms and endometrial cancer.Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.Novel Immune Mechanisms in Hypertension and Cardiovascular Risk.Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genomeBeyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension.The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.Neurogenic hypertension: revelations from genome-wide gene expression profiling.Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.Application of microRNAs in diagnosis and treatment of cardiovascular disease.Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polymorphism and coronary artery disease in Chinese populations.A1166C polymorphism of the angiotensin II type 1 receptor gene contributes to hypertension susceptibility: evidence from a meta-analysis.MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia.Role of MicroRNA in Endothelial Dysfunction and Hypertension.Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure.Circulating levels and characterization of microparticles in patients with different degrees of glucose toleranceMicroRNA-155 Regulates ROS Production, NO Generation, Apoptosis and Multiple Functions of Human Brain Microvessel Endothelial Cells Under Physiological and Pathological Conditions.Association between polymorphisms in the renin-angiotensin system genes and prevalence of spontaneously aborted fetuses.Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease.Analysis of Association of Angiotensin II Type 1 Receptor Gene A1166C Gene Polymorphism with Essential Hypertension.Circulating miR155 expression level is positive with blood pressure parameters: Potential markers of target-organ damage.The A(1166)C polymorphism of the AT1R gene is associated with an early onset of hypertension and high waist circumference in Jordanian males attending the Jordan University Hospital.Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population.
P2860
Q26786428-9AEE34C0-BC4E-4FAE-BBCD-D97A427BD606Q27012757-33251E40-E811-4F58-A501-18710B4C30A3Q28079163-49012798-0000-49E0-8DBE-3B5DFAAD57FEQ33359407-6DDF749B-B5E8-47DC-9F08-48F953AF1763Q33362101-F7F8E371-3EAB-4758-A694-3842B931D4DDQ33845334-84BCA333-5520-4DEC-8118-AE3F250A788FQ34116143-5781229B-1574-45A7-BF51-1ADCFA981F39Q34179000-BC3CD04F-50F7-41BF-B40B-0235B64BEB5BQ35178127-FA02DB25-169C-4986-BD7E-B62AADC90418Q35907336-B9BA0604-C51F-42DD-96AB-5BA9D62B80B8Q36139956-53472824-4FEA-4E96-A07F-18AD63599BCBQ36173562-0E0E2447-FDF4-412D-9305-C811D7B34574Q36175435-B7EF2E65-9746-4702-AA33-6189D3B73D5FQ36795264-985A6535-84BE-48EC-9B37-76FD18F5ADD2Q36806610-3E0AADC7-4123-408B-9772-47034E54571AQ37212921-D628661A-8A38-48D6-85DA-CF99B3B55FC3Q37277242-EEAB9DBA-5BD7-4DE7-95A3-2CD82B80D6A1Q37683209-90CBBC00-995D-4BF0-A54C-08BFF56613DBQ37741539-BEA2A3C0-D2CD-48C7-BAF4-5E1619C93E66Q37939725-56752B64-14EF-4347-BB8C-97224EBFA83CQ37998958-48FE5EA4-B37A-45AD-A9C9-8CD4FFB05C59Q38013692-D6FC3F74-5597-4F4E-A0DE-12BFF2A083E6Q38153192-F01CDC93-9160-4D32-83C4-92550AC9D051Q38264294-4DF1C0B9-7952-44E5-9534-1E0040456A39Q38274805-EB8DF2A8-9B23-4355-B2D0-89605B3FC67DQ38415290-6FFD3013-1020-4C0D-92BB-EF6812724E9DQ38734704-5FF8F35E-234B-494F-813F-4CC4CF75226BQ38808277-BEACA6FB-B6BB-464A-A6D1-4520C5C988A1Q39006068-262FFA10-9AD2-4CA7-8DA5-B49C744D2B5AQ39015639-D5E2D5D5-2716-4594-A861-8838154AD89EQ39386976-C9222770-142C-4CFE-854E-1310BCC6D74FQ41228757-4AF772B4-4C5E-45AE-A0DE-DFF1226A0596Q41712425-3D2F5FC0-7B2B-4868-B320-AAEBA801CFBFQ42477499-903DC4D0-F04A-434A-A8FE-8A932B4B7DFDQ43581806-0A1367E2-5CD3-4857-9976-C66BDB89C071Q47137535-80652ACF-D73C-4171-8478-32E8A985E6F7Q49679359-9866BF2D-0248-4FF1-9DAE-ABCC492B89EDQ50678900-3334EC01-2B8F-4BBE-BEA9-2E0635046F5FQ50772095-17B31BE0-0BFC-45DB-B6EE-B1ACEF7633EAQ50969065-CBC63138-9258-44A9-8776-95617B8A49B8
P2860
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@ast
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@en
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@nl
type
label
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@ast
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@en
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@nl
prefLabel
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@ast
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@en
Interplay between miR-155, AT1 ...... young untreated hypertensives.
@nl
P2093
P50
P356
P1476
Interplay between miR-155, AT1 ...... young untreated hypertensives
@en
P2093
Alessia Bortoluzzi
Elisa Squarcina
Fabio Ragazzo
Giacomo Strapazzon
Italia Papparella
Paolo Bratti
Paolo Palatini
P304
P356
10.1038/AJH.2010.211
P577
2010-10-21T00:00:00Z